Lejian He

558 total citations
55 papers, 335 citations indexed

About

Lejian He is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Lejian He has authored 55 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 14 papers in Pathology and Forensic Medicine and 12 papers in Neurology. Recurrent topics in Lejian He's work include Sarcoma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (11 papers) and Tumors and Oncological Cases (10 papers). Lejian He is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (11 papers) and Tumors and Oncological Cases (10 papers). Lejian He collaborates with scholars based in China, United States and Russia. Lejian He's co-authors include Libing Fu, Xin Ni, Yongli Guo, Huanmin Wang, Xiaoman Wang, Jun Tai, Liqun Jia, Jie Zhang, Mei Jin and Meng Zhang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Human Pathology and The Pediatric Infectious Disease Journal.

In The Last Decade

Lejian He

49 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lejian He China 10 118 91 69 61 56 55 335
Livia Salmi Italy 10 106 0.9× 50 0.5× 22 0.3× 60 1.0× 65 1.2× 18 359
Naruhiro Kimura Japan 12 83 0.7× 35 0.4× 30 0.4× 115 1.9× 35 0.6× 46 422
Lara Matilla Spain 12 86 0.7× 67 0.7× 12 0.2× 73 1.2× 27 0.5× 23 367
Akihiro Tsukadaira Japan 11 39 0.3× 178 2.0× 99 1.4× 63 1.0× 86 1.5× 28 434
Anna Birnhuber Austria 10 93 0.8× 159 1.7× 33 0.5× 38 0.6× 22 0.4× 14 354
Diganta Hazarika India 12 40 0.3× 173 1.9× 37 0.5× 52 0.9× 119 2.1× 31 348
İbrahım Pirim Türkiye 12 153 1.3× 33 0.4× 14 0.2× 52 0.9× 22 0.4× 59 419
H Mizote Japan 11 54 0.5× 71 0.8× 103 1.5× 117 1.9× 23 0.4× 39 296
Domenico Loizzi Italy 13 79 0.7× 210 2.3× 22 0.3× 170 2.8× 64 1.1× 33 467
Abbas Shahi Iran 10 72 0.6× 38 0.4× 42 0.6× 91 1.5× 35 0.6× 25 344

Countries citing papers authored by Lejian He

Since Specialization
Citations

This map shows the geographic impact of Lejian He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lejian He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lejian He more than expected).

Fields of papers citing papers by Lejian He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lejian He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lejian He. The network helps show where Lejian He may publish in the future.

Co-authorship network of co-authors of Lejian He

This figure shows the co-authorship network connecting the top 25 collaborators of Lejian He. A scholar is included among the top collaborators of Lejian He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lejian He. Lejian He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, William W., Shijie Ren, Lejian He, et al.. (2025). A Network Information-Based Behavior Change Wheel for Populations at High Risk of Developing Gastric Cancer. Journal of Cancer Education. 41(1). 115–122.
2.
He, Lejian, et al.. (2025). BCOR Mutations Identify a Clinically Aggressive Subset of Pediatric Rhabdomyosarcoma. Fetal and Pediatric Pathology. 45(1). 38–43.
3.
Feng, Xiao, et al.. (2024). ALK-positive histiocytosis in 12 Asian children. Human Pathology. 152. 105637–105637. 2 indexed citations
4.
Duan, Chao, Xiaoli Ma, Shengcai Wang, et al.. (2024). Clinical outcomes and prognostic factors of parameningeal rhabdomyosarcoma in children and adolescents: results of two consecutive protocols. Translational Pediatrics. 13(7). 1086–1096.
5.
Liu, Shan, Jun Feng, Qinghua Ren, et al.. (2023). Evaluating the clinical efficacy and limitations of indocyanine green fluorescence-guided surgery in childhood hepatoblastoma: A retrospective study. Photodiagnosis and Photodynamic Therapy. 44. 103790–103790. 4 indexed citations
6.
Cheng, Yin, et al.. (2023). Expression of TFE3 in Cellular and Myxoid Type of Neurothekeoma: Four Cases in Young Children and Adolescents. Fetal and Pediatric Pathology. 42(4). 679–684. 1 indexed citations
7.
Yu, Yongbo, Meng Zhang, Chao Jia, et al.. (2023). Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements. The Journal of Pathology Clinical Research. 9(6). 475–487. 1 indexed citations
8.
Jia, Chao, Tieshan Wang, Wenjing Liu, et al.. (2023). Acquired CFTR dysfunction and dense distribution of ionocytes in nasal mucosa of children with CRS. European Archives of Oto-Rhino-Laryngology. 280(7). 3237–3247. 2 indexed citations
9.
Feng, Jun, Wei Yang, Hong Qin, et al.. (2023). Clinical application of indocyanine green fluorescence imaging navigation for pediatric renal cancer. Frontiers in Pediatrics. 11. 1108997–1108997. 12 indexed citations
10.
Feng, Xiao, et al.. (2023). Desmoplastic small round cell tumor of the liver: diagnosing a rare case on liver biopsy. Diagnostic Pathology. 18(1). 84–84. 2 indexed citations
11.
Wang, Shengcai, Ping Chu, Yaqiong Jin, et al.. (2022). Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors. Journal of Pediatric Surgery. 57(12). 926–933.
12.
Lian, Hongyun, Ang Wei, Lejian He, et al.. (2021). Clinical Analysis of Pediatric Systemic Juvenile Xanthogranulomas: A Retrospective Single-Center Study. Frontiers in Pediatrics. 9. 672547–672547. 4 indexed citations
13.
Zhang, Meng, et al.. (2021). A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children. Pathology - Research and Practice. 230. 153754–153754. 7 indexed citations
14.
Huang, Cheng, Yan Su, Lejian He, et al.. (2021). Clinical features and prognosis of paediatric rhabdomyosarcoma with bone marrow metastasis: a single Centre experiences in China. BMC Pediatrics. 21(1). 463–463. 6 indexed citations
15.
Su, Yan, Chenghao Chen, Lejian He, et al.. (2020). Acute myeloid leukemia following a primary mediastinal germ cell tumor. Pediatric Investigation. 4(3). 218–221. 3 indexed citations
16.
Tai, Jun, Shengcai Wang, Jie Zhang, et al.. (2018). Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics. European Archives of Oto-Rhino-Laryngology. 275(11). 2823–2828. 10 indexed citations
17.
Fu, Libing, Yaqiong Jin, Chao Jia, et al.. (2017). Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma. Science China Life Sciences. 60(7). 721–728. 5 indexed citations
18.
Li, Qiliang, Wenqi Song, Xiaoxia Peng, et al.. (2015). Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children. World Journal of Pediatrics. 11(3). 276–280. 8 indexed citations
19.
Hu, Huili, et al.. (2008). THE ROLE OF HAEMOPHILUS INFLUENZAE TYPE b IN FATAL COMMUNITY-ACQUIRED PNEUMONIA IN CHINESE CHILDREN. The Pediatric Infectious Disease Journal. 27(10). 942–944. 6 indexed citations
20.
Fu, Libing & Lejian He. (2005). [Langerhans' cell histiocytosis].. PubMed. 34(11). 752–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026